Cargando…
Identification of novel prostate cancer genes in patients stratified by Gleason classification: Role of antitumoral genes
Prostate cancer (PCa) is a tumor with a great heterogeneity, both at a molecular and clinical level. Despite its global good prognosis, cases can vary from indolent to lethal metastatic and scientific efforts are aimed to discern those with worse outcomes. Current prognostic markers, as Gleason scor...
Autores principales: | Díaz de la Guardia‐Bolívar, Elisa, Barrios‐Rodríguez, Rocío, Zwir, Igor, Jiménez‐Moleón, José Juan, del Val, Coral |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311191/ https://www.ncbi.nlm.nih.gov/pubmed/35234293 http://dx.doi.org/10.1002/ijc.33988 |
Ejemplares similares
-
Using linkage studies combined with whole‐exome sequencing to identify novel candidate genes for familial colorectal cancer
por: Toma, Claudio, et al.
Publicado: (2019) -
Age‐stratified reference intervals unlock the clinical potential of circulating cell‐free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer
por: Ørntoft, Mai‐Britt Worm, et al.
Publicado: (2020) -
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
por: Girard, Elodie, et al.
Publicado: (2018) -
The distribution of BRAF gene fusions in solid tumors and response to targeted therapy
por: Ross, Jeffrey S., et al.
Publicado: (2016) -
Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas
por: Agostini, Antonio, et al.
Publicado: (2018)